Approval · Notice of Compliance 1404 · 2000
ACTOS: Notice of Compliance 1404
Issued August 17, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1404
- Date
- August 17, 2000
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Anti-diabetic agent
Products in this notice
Medicinal ingredients
- PIOGLITAZONE HYDROCHLORIDE 15 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 30 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 45 MG per TAB